Collaborations Pharmaceuticals, Inc. Introduce Batten Disease CLN1 Registry In Order to Find Patients
Collaborations Pharmaceuticals, Inc. has developed a registry for Batten Disease CLN1 In order to find patients with this rare disease and gather information. RALEIGH, NC, USA, April 11, 2024 /EINPresswire.com/ -- “We are proud to announce the release …